These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26599956)

  • 1. Prevalence of Hyperkalemia in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease: A Nested Case-Control Study.
    Loutradis C; Tolika P; Skodra A; Avdelidou A; Sarafidis PA
    Am J Nephrol; 2015; 42(5):351-60. PubMed ID: 26599956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on serum potassium levels and renal function in ambulatory outpatients: risk factors analysis.
    Maddirala S; Khan A; Vincent A; Lau K
    Am J Med Sci; 2008 Oct; 336(4):330-5. PubMed ID: 18854676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease.
    Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2019; 39(5):513-522. PubMed ID: 31027897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence and related factors of hyperkalemia in patients with diabetic kidney disease].
    Li SY; Li GP; Wang L; Duan JY; Chen WQ; Pan SK; Liu ZS; Liu DW
    Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(42):3478-3483. PubMed ID: 34775705
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic.
    Sarafidis PA; Blacklock R; Wood E; Rumjon A; Simmonds S; Fletcher-Rogers J; Ariyanayagam R; Al-Yassin A; Sharpe C; Vinen K
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1234-41. PubMed ID: 22595825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperkalemia in chronic heart failure with renal dysfunction or diabetes mellitus: Results from the TREAT HF study.
    Murat S; Kaya H; Çavuşoğlu Y; Yılmaz MB
    Turk Kardiyol Dern Ars; 2021 Apr; 49(3):198-205. PubMed ID: 33847269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperkalemia in pediatric chronic kidney disease.
    Kurzinski KL; Xu Y; Ng DK; Furth SL; Schwartz GJ; Warady BA;
    Pediatr Nephrol; 2023 Sep; 38(9):3083-3090. PubMed ID: 36939915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.
    Lepage L; Dufour AC; Doiron J; Handfield K; Desforges K; Bell R; Vallée M; Savoie M; Perreault S; Laurin LP; Pichette V; Lafrance JP
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2136-42. PubMed ID: 26576619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort study.
    Thomsen RW; Nicolaisen SK; Hasvold P; Sanchez RG; Pedersen L; Adelborg K; Egstrup K; Egfjord M; Sørensen HT
    Nephrol Dial Transplant; 2018 Sep; 33(9):1610-1620. PubMed ID: 29177463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.
    Bakris GL; Pitt B; Weir MR; Freeman MW; Mayo MR; Garza D; Stasiv Y; Zawadzki R; Berman L; Bushinsky DA;
    JAMA; 2015 Jul; 314(2):151-61. PubMed ID: 26172895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Metabolic Acidosis Among Patients with Chronic Kidney Disease and Hyperkalemia.
    Cook EE; Davis J; Israni R; Mu F; Betts KA; Anzalone D; Yin L; Szerlip H; Uwaifo GI; Fonseca V; Wu EQ
    Adv Ther; 2021 Oct; 38(10):5238-5252. PubMed ID: 34471991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction and management of hyperkalemia across the spectrum of chronic kidney disease.
    Lazich I; Bakris GL
    Semin Nephrol; 2014 May; 34(3):333-9. PubMed ID: 25016403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease: A nested case-control study.
    Loutradis C; Skodra A; Georgianos P; Tolika P; Alexandrou D; Avdelidou A; Sarafidis PA
    World J Nephrol; 2016 Jul; 5(4):358-66. PubMed ID: 27458564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degrees of chronic renal insufficiency.
    Li Vecchi M; Fuiano G; Francesco M; Mancuso D; Faga T; Sponton A; Provenzano R; Andreucci M; Tozzo C
    Nephron Clin Pract; 2007; 105(2):c62-7. PubMed ID: 17135770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk for hyperkalemia during long-term treatment with angiotensin-converting enzyme inhibitors in insulin-dependent type 2 diabetics in relation to the glomerular filtration rate].
    Raml A; Schmekal B; Grafinger P; Biesenbach G
    Dtsch Med Wochenschr; 2001 Nov; 126(47):1327-30. PubMed ID: 11719857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal potassium handling in chronic kidney disease: Differences between patients with or wihtout hyperkalemia.
    Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2020; 40(2):152-159. PubMed ID: 31353054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of Hyperkalemia Progression Among Patients with Mild Hyperkalemia.
    Israni R; Betts KA; Mu F; Davis J; Wang J; Anzalone D; Uwaifo GI; Szerlip H; Fonseca V; Wu E
    Adv Ther; 2021 Nov; 38(11):5596-5608. PubMed ID: 34622391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of hyperkalemia risk after hypertension control with aldosterone blockade according to the presence or absence of chronic kidney disease.
    Gwoo S; Kim YN; Shin HS; Jung YS; Rim H
    Nephron Clin Pract; 2014; 128(3-4):381-6. PubMed ID: 25572273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology.
    Bianchi S; Aucella F; De Nicola L; Genovesi S; Paoletti E; Regolisti G
    J Nephrol; 2019 Aug; 32(4):499-516. PubMed ID: 31119681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperkalemia and Hypokalemia in CKD: Prevalence, Risk Factors, and Clinical Outcomes.
    Gilligan S; Raphael KL
    Adv Chronic Kidney Dis; 2017 Sep; 24(5):315-318. PubMed ID: 29031358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.